Global Headache Disorders Market Report 2024: Growth Rate, Major Segments And Regions


Posted January 31, 2024 by ramtbrc

The headache disorders market size is expected to see strong growth in the next few years. It will grow to $6.42 billion in 2028 at a compound annual growth rate (CAGR) of 8.1%.

 
The Headache Disorders by The Business Research Company provides market overview across 60+ geographies in the seven regions - Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa, encompassing 27 major global industries. The report presents a comprehensive analysis over a ten-year historic period (2010-2021) and extends its insights into a ten-year forecast period (2023-2033).

Learn More On The Headache Disorders Market:
https://www.thebusinessresearchcompany.com/report/headache-disorders-global-market-report

According to The Business Research Company’s Headache Disorders, The headache disorders market size has grown strongly in recent years. It will grow from $4.37 billion in 2023 to $4.7 billion in 2024 at a compound annual growth rate (CAGR) of 7.4%. The growth in the historic period can be attributed to limited treatment options, growing awareness, rising incidence of headaches, evolving healthcare infrastructure, shift in lifestyle and stress levels.

The headache disorders market size is expected to see strong growth in the next few years. It will grow to $6.42 billion in 2028 at a compound annual growth rate (CAGR) of 8.1%. The growth in the forecast period can be attributed to digital health solutions, personalized medicine approaches, increasing research and development investments, global aging population, expansion of research in neuroinflammation. Major trends in the forecast period include technological advancements in treatment, personalized medicine, increased focus on preventive therapies, expanding pipeline of novel therapies, rise in non-pharmacological approaches.

The increasing prevalence of migraine is expected to propel the growth of the headache disorders market going forward. Migraine refers to a type of headache that is characterized by recurring episodes of moderate to severe throbbing and pulsating pain on one side of the head. Headache disorders can cause neurological disorders causing crippling throbbing pain, tiredness, and nausea that may cause migraine. For instance, according to Migraine.com, part of US-based Health Union, LLC which provide people living with chronic conditions the information, connection, and validation they seek, in 2021, around 39 million people in the United States and 1 billion people worldwide have migraine. Therefore, the increasing prevalence of migraine is driving the demand for the headache disorders market.

Get A Free Sample Of The Report (Includes Graphs And Tables):
https://www.thebusinessresearchcompany.com/sample.aspx?id=9452&type=smp

The headache disorders market covered in this report is segmented –
1) By Type: Migraine, Tension-Type Headache, Cluster Headache, Medication-Overuse Headache, Other Types
2) By Treatment: Medication, Heat Therapy, Diet Changes, Acupuncture, Oxygen Therapy
3) By Diagnosis: Complete Blood Count, Skull X-Rays, Sinus X-Rays, CT Scan, Magnetic Resonance Imaging (MRI)
4) By Route Of Administration: Oral, Parenteral, Other Route Of Administrations
5) By End-User: Hospitals, Specialty Clinics, Homecare, Other End-Users

Product innovation is a key trend gaining popularity in the headache disorder market. Major companies operating in the headache disorder market are focused on developing innovative products to strengthen their position in the market. For instance, in September 2021, AbbVie, a US-based pharmaceutical company that discovers develops, and markets both biopharmaceuticals and small molecule drugs, launched QULIPTATM (atonement) a prescription medicine for the preventative treatment of episodic migraine in adults. It is uniquely formulated with oral calcitonin gene-related peptide (CGRP) receptor antagonist (giant) in three dose sizes of 10 mg, 30 mg, and 60 mg which are approved by The U.S. Food and Drug Administration (FDA), a US-based department of health.

The headache disorders market report table of contents includes:
1. Executive Summary
2. Headache Disorders Market Characteristics
3. Headache Disorders Market Trends And Strategies
4. Headache Disorders Market - Macro Economic Scenario
5. Global Headache Disorders Market Size and Growth
.
31. Global Headache Disorders Market Competitive Benchmarking
32. Global Headache Disorders Market Competitive Dashboard
33. Key Mergers And Acquisitions In The Headache Disorders Market
34. Headache Disorders Market Future Outlook and Potential Analysis
35. Appendix

Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: [email protected]

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
-- END ---
Share Facebook Twitter
Print Friendly and PDF DisclaimerReport Abuse
Contact Email [email protected]
Issued By The Business Research Company
Country United States
Categories Advertising
Tags headache disorders market size
Last Updated January 31, 2024